A protein truncating BRCA1 allele with a low penetrance of breast cancer.
作者信息
Gorski B, Menkiszak J, Gronwald J, Lubinski J, Narod S A
机构信息
Department of Genetics and Pathology, International Hereditary Cancer Centre, Pomeranian Medical University, Szczecin, Poland.
出版信息
J Med Genet. 2004 Dec;41(12):e130. doi: 10.1136/jmg.2004.019430.
Abstract
摘要
相似文献
1
A protein truncating BRCA1 allele with a low penetrance of breast cancer.
J Med Genet. 2004 Dec;41(12):e130. doi: 10.1136/jmg.2004.019430.
2
The RAD51 135 G>C polymorphism modifies breast cancer and ovarian cancer risk in Polish BRCA1 mutation carriers.
Cancer Epidemiol Biomarkers Prev. 2007 Feb;16(2):270-5. doi: 10.1158/1055-9965.EPI-06-0562.
3
BRCA1 and BRCA2 mutation predictions using the BOADICEA and BRCAPRO models and penetrance estimation in high-risk French-Canadian families.
Breast Cancer Res. 2006;8(1):R3. doi: 10.1186/bcr1365. Epub 2005 Dec 12.
4
The average cumulative risks of breast and ovarian cancer for carriers of mutations in BRCA1 and BRCA2 attending genetic counseling units in Spain.
Clin Cancer Res. 2008 May 1;14(9):2861-9. doi: 10.1158/1078-0432.CCR-07-4436.
5
Methyl group metabolism gene polymorphisms as modifier of breast cancer risk in Italian BRCA1/2 carriers.
Breast Cancer Res Treat. 2007 May;103(1):29-36. doi: 10.1007/s10549-006-9349-y. Epub 2006 Dec 7.
6
Breast cancer predisposing alleles in Poland.
Breast Cancer Res Treat. 2005 Jul;92(1):19-24. doi: 10.1007/s10549-005-1409-1.
7
Gross rearrangements in BRCA1 but not BRCA2 play a notable role in predisposition to breast and ovarian cancer in high-risk families of German origin.
Cancer Genet Cytogenet. 2006 Jul 1;168(1):44-9. doi: 10.1016/j.cancergencyto.2005.07.005.
8
Incidence of BRCA1 and BRCA2 mutations in 54 Chilean families with breast/ovarian cancer, genotype-phenotype correlations.
Breast Cancer Res Treat. 2006 Jan;95(1):81-7. doi: 10.1007/s10549-005-9047-1. Epub 2005 Oct 27.
9
Breast and ovarian cancer.
N Engl J Med. 2003 Jun 5;348(23):2339-47. doi: 10.1056/NEJMra012284.
10
Common BRCA2 variants and modification of breast and ovarian cancer risk in BRCA1 mutation carriers.
Cancer Epidemiol Biomarkers Prev. 2005 Jan;14(1):265-7.
引用本文的文献
1
Genotype-phenotype correlations among BRCA1 4153delA and 5382insC mutation carriers from Latvia.
BMC Med Genet. 2011 Oct 27;12:147. doi: 10.1186/1471-2350-12-147.
2
BRCA1 4153delA founder mutation in Russian ovarian cancer patients.
Hered Cancer Clin Pract. 2006 Sep 15;4(4):193-6. doi: 10.1186/1897-4287-4-4-193.
3
Principles of genetic predisposition to malignancies.
Hered Cancer Clin Pract. 2008 Jun 15;6(2):69-72. doi: 10.1186/1897-4287-6-2-69.
4
The contribution of BRCA1 and BRCA2 to ovarian cancer.
Mol Oncol. 2009 Apr;3(2):138-50. doi: 10.1016/j.molonc.2009.02.001. Epub 2009 Feb 10.
5
Cancer risks in first degree relatives of BRCA1 mutation carriers: effects of mutation and proband disease status.
J Med Genet. 2006 May;43(5):424-8. doi: 10.1136/jmg.2005.036921. Epub 2005 Oct 14.
Zotero 插件